Biologics Regulatory CERAMENT® V application in the U.S. transferred to the De Novo process byWill SandbergDecember 2, 2025
Biologics Extremities Top Stories Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion byWill SandbergDecember 2, 2025
Biologics Acuitive Technologies introduces Citregraft, a unique bone graft substitute designed to bind proteins and enhance regeneration byTim AllenNovember 26, 2025
Biologics Recon Regulatory Aesculap Implant Systems Resolves Long-Pending Federal Investigations byJosh SandbergNovember 17, 2025
Biologics Regulatory Spine BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease byJosh SandbergNovember 17, 2025
Biologics Regulatory Rapid Nexus Becomes the First Company to Receive FDA Clearance for its Advanced Wound-Healing Device Hemastyl byWill SandbergNovember 13, 2025
Biologics Financial Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business byWill SandbergNovember 13, 2025
Biologics Financial Regenerative Medicine Market Research Report 2025 Featuring Stryker, Athersys, Integra Lifesciences, Isto Biologics, Organogenesis, CryoLife, Medtronic, U.S. Stem Cell, Zimmer Biomet, and 3M byTim AllenNovember 11, 2025
Biologics TAICEND’s Patented Fish Collagen Technology Brings a Breakthrough in the Healing of Hard-to-Heal Wounds byNoah SimmonsNovember 7, 2025
Biologics Spine Fziomed Initiates Commercialization of Oxiplex Gel in the United States byJosh SandbergNovember 5, 2025